Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Amoxicillin-clavulanate in Children with Acute Respiratory Infection and Nasal Bacteria
NCT00545961Phase 4Unknown
- Sponsor
- Oulu University Hospital
- Start
- Nov 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in Acute Respiratory Infection (ARI) and sinusitis comparing Placebo with Amoxicillin-clavulanate (2 arms). Primary endpoint: Duration of continuous daily symptoms of the acute respiratory infection at 3 weeks. Status: unknown.
02
Drugs
amoxicillin + clavulanate
03
Conditions
Acute Respiratory Infection (ARI)sinusitis
Beyond the preview
Go deeper on NCT00545961.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00545961.